Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT05658133
Eligibility Criteria:
Inclusion Criteria for Athletes
1. Participants are male or female between 14-19 years of age, inclusive.
2. Participants must be participating on a high school varsity team, or Amateur Athletic Union, National, or State travel team.
3. Participants must be attending high school in the United States.
4. Participant understands what is required to complete the study and signs forms providing informed consent to complete the questionnaire
5. Participant or legal guardian is able and willing to sign the Informed Consent Form.
Inclusion Criteria for Influencers
1. Participants must be currently coaching, or a practitioner for a high school varsity team, or an Amateur Athletic Union, National, or State, travel team of high school students aged (14-19 years).
2. Participants must work with/at a high school in the United States.
3. Participant understands what is required to complete the study and signs forms providing informed consent to complete the questionnaire
Exclusion Criteria for Athletes
1. Participant has a condition the Investigator believes would interfere with his or her ability to provide informed consent, which might put the individual at undue risk.
2. Participant is pregnant.
Exclusion Criteria for Influencers
1\. Participant has a condition the Investigator believes would interfere with his or her ability to provide informed consent, which might put the individual at undue risk.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
19 Years
Study:
NCT05658133
Study Brief:
Protocol Section:
NCT05658133